Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 12/20 | 0.42 |
| ▸ | CTSS | P25774 | 6/20 | 0.42 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.38 |
| ▸ | CTSL | P07711 | 1/20 | 0.37 |
| ▸ | CTSB | P07858 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16579319 | 0.89 | CTSK (0.44) | CTSKCTSSCAPN1CTSLCTSB | |
| SCHEMBL30196313 | 0.88 | CTSK (0.47) | CTSKCTSSCAPN1CTSLCTSB | |
| SCHEMBL8140881 | 0.84 | CTSK (0.48) | CTSKCTSSCAPN1CTSLCTSB | |
| SCHEMBL20669522 | 0.81 | CTSK (0.43) | CTSKCTSSCAPN1CTSLCTSB | |
| SCHEMBL20669524 | 0.81 | CTSS (0.63) | CTSKCTSSCTSLCTSBL3MBTL1 | |
| SCHEMBL28272672 | 0.80 | CA1 (0.44) | CTSKCTSSCTSLCTSBKMT2A | |
| SCHEMBL16579343 | 0.80 | CA1 (0.44) | CTSKCTSSCTSLCTSBKMT2A | |
| SCHEMBL15936967 | 0.79 | CTSK (0.49) | CTSKCTSSCAPN1CTSLCTSB | |
| SCHEMBL16317053 | 0.78 | CTSK (0.53) | CTSKCTSSCAPN1CTSLCTSB | |
| SCHEMBL15289834 | 0.78 | CTSK (0.49) | CTSKCTSSCAPN1CTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160222430-A1 | D-ALA-D-ALA-BASED DIPEPTIDES AS TOOLS FOR IMAGING PEPTIDOGLYCAN BIOSYNTHESIS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION | 2016-08-04 | — | — | US | disclosed |
| WO-2015038764-A1 | D-ALA-D-ALA-BASED DIPEPTIDES AS TOOLS FOR IMAGING PEPTIDOGLYCAN BIOSYNTHESIS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2015-03-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160222430-A1 | D-ALA-D-ALA-BASED DIPEPTIDES AS TOOLS FOR IMAGING PEPTIDOGLYCAN BIOSYNTHESIS | DNPEP, DDOST, ALAD | CTSK 2038/4885CTSS 3002/4885CAPN1 3356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.